Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 21, 2020; 26(3): 335-352
Published online Jan 21, 2020. doi: 10.3748/wjg.v26.i3.335
Published online Jan 21, 2020. doi: 10.3748/wjg.v26.i3.335
Sub pathway | Biochemical name | Fold difference ascending/descending | |||||
NW | P value | OW | P value | OB | P value | ||
Long chain fatty acids | Palmitate (16:0) | 1.3 | 0.02 | 1.0 | 0.75 | 0.7 | 0.04 |
5 | 1 | 4 | 4 | 3 | 4 | ||
Margarate (17:0) | 1.2 | 0.13 | 0.8 | 0.33 | 0.7 | 0.03 | |
1 | 1 | 8 | 1 | 7 | |||
Stearate (18:0) | 1.3 | 0.01 | 0.9 | 0.61 | 0.6 | 0.01 | |
9 | 3 | 4 | 5 | 8 | 6 | ||
Oleate/vaccenate (18:1) | 1.5 | 0.04 | 1.2 | 0.36 | 0.9 | 0.80 | |
8 | 5 | 4 | 0 | ||||
Nonadecanoate (19:0) | 1.1 | 0.29 | 0.8 | 0.26 | 0.6 | 0.01 | |
2 | 8 | 5 | 9 | 1 | |||
Arachidate (20:0) | 1.3 | 0.02 | 0.9 | 0.56 | 0.6 | 0.02 | |
5 | 5 | 3 | 4 | 9 | 5 | ||
Eicosenoate (20:1) | 1.4 | 0.04 | 1.1 | 0.56 | 1.0 | 0.88 | |
8 | 1 | 1 | 2 | 3 | 3 | ||
Erucate (22:1n9) | 1.5 | 0.03 | 1.0 | 0.81 | 1.1 | 0.47 | |
2 | 1 | 4 | 1 | 8 | 2 | ||
Polyunsaturated fatty acid | Dihomo-linolenate (20:3n3 or n6) | 1.5 | 0.04 | 1.2 | 0.28 | 1.1 | 0.56 |
9 | 1 | 6 | 5 | 6 | 7 | ||
Dihomo-linoleate (20:2n6) | 1.6 | 0.01 | 1.1 | 0.41 | 1.2 | 0.46 | |
8 | 7 | 8 | 7 | 3 | |||
Fatty acid, dicarboxylate | Dodecadienoate (12:2)1 | 0.9 | 0.64 | 0.8 | 0.26 | 0.7 | 0.03 |
5 | 5 | 7 | 1 | 1 | 2 | ||
Ketone bodies | 3-hydroxybutyrate (BHBA) | 0.4 | 0.00 | 0.9 | 0.90 | 1.0 | 0.82 |
8 | 5 | 7 | 4 | 7 | 5 | ||
Fatty acid, metabolism (Acyl choline) | Linoleoylcholine1 | 1.2 | 0.34 | 1.1 | 0.62 | 2.0 | 0.02 |
6 | 4 | 3 | 6 | 1 | |||
Fatty acid, monohydroxy | 2-hydroxystearate | 1.3 | 0.04 | 0.9 | 0.67 | 0.7 | 0.13 |
2 | 5 | 7 | 9 | 5 | |||
Eicosanoid | 15-HETE | 1.6 | 0.04 | 1.1 | 0.51 | 1.9 | 0.03 |
9 | 5 | 8 | 5 | 3 | 9 | ||
Endocannabinoid | Oleoyl ethanolamide | 1.6 | 0.03 | 2.2 | 0.79 | 1.5 | 0.10 |
8 | 3 | 5 | 9 | ||||
Palmitoyl ethanolamide | 1.3 | 0.02 | 1.0 | 0.56 | 1.1 | 0.42 | |
7 | 4 | 8 | 1 | 4 | 1 | ||
Linoleoyl ethanolamide | 2.1 | 0.00 | 1.2 | 0.35 | 1.5 | 0.17 | |
1 | 5 | 6 | 1 | 2 | 1 | ||
Phosphatidylethanolamine | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) | 0.8 | 0.28 | 0.6 | 0.01 | 0.7 | 0.15 |
1 | 4 | 6 | 6 | ||||
1-stearoyl-2-linoleoyl-GPE (18:0/18:2)1 | 0.9 | 0.87 | 0.6 | 0.04 | 0.6 | 0.09 | |
7 | 5 | 5 | 3 | 5 | 7 | ||
1,2-dioleoyl-GPE (18:1/18:1) | 0.6 | 0.07 | 0.6 | 0.03 | 0.7 | 0.19 | |
9 | 5 | 8 | 3 | ||||
1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6)1 | 0.6 | 0.01 | 0.7 | 0.08 | 0.4 | 0.00 | |
2 | 3 | 1 | 3 | 1 | |||
Lysophospholipid | 1-palmitoleoyl-GPC (16:1)1 | 1.5 | 0.03 | 1.3 | 0.20 | 1.2 | 0.33 |
9 | 6 | 1 | 2 | 8 | 3 | ||
1-linoleoyl-GPC (18:2) | 1.6 | 0.00 | 1.5 | 0.01 | 1.4 | 0.08 | |
8 | 7 | 1 | 3 | 5 | |||
1-arachidonoyl-GPC (20:4n6)1 | 1.74 | 0.035 | 1.55 | 0.092 | 1.39 | 0.285 | |
1-linoleoyl-GPS (18:2)1 | 1.8 | 0.00 | 1.4 | 0.07 | 1.2 | 0.31 | |
9 | 2 | 1 | 7 | 6 | 4 | ||
1-palmitoyl-GPG (16:0)1 | 2.1 | 0.00 | 1.3 | 0.18 | 0.8 | 0.51 | |
1 | 5 | 8 | 3 | 3 | 5 | ||
1-stearoyl-GPG (18:0) | 2.1 | 0.00 | 1.3 | 0.16 | 0.8 | 0.66 | |
6 | 2 | 6 | 9 | 5 | |||
1-oleoyl-GPG (18:1)1 | 1.6 | 0.01 | 1.0 | 0.66 | 1.1 | 0.47 | |
7 | 8 | 6 | 6 | ||||
1-palmitoyl-GPI (16:0) | 1.5 | 0.04 | 1.1 | 0.55 | 0.7 | 0.31 | |
8 | 1 | 3 | 4 | 7 | 8 | ||
1-stearoyl-GPI (18:0) | 1.4 | 0.03 | 1.0 | 0.66 | 0.8 | 0.50 | |
9 | 4 | 8 | 3 | 7 | 7 | ||
1-oleoyl-GPI (18:1) | 1.6 | 0.02 | 1.2 | 0.24 | 0.9 | 0.81 | |
4 | 7 | 8 | 7 | 4 | 8 | ||
1-linoleoyl-GPI (18:2)1 | 1.4 | 0.01 | 1.1 | 0.48 | 1.2 | 0.22 | |
8 | 7 | 1 | 8 | 6 | 5 | ||
Plasmalogen | 1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1)1 | 0.7 | 0.08 | 0.6 | 0.02 | 0.6 | 0.13 |
1 | 9 | 2 | 2 | 9 | 8 | ||
1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)1 | 0.7 | 0.10 | 0.6 | 0.01 | 0.7 | 0.16 | |
4 | 5 | 3 | 9 | 3 | |||
1-(1-enyl-stearoyl)-2-oleoyl-GPE (P-18:0/18:1) | 0.7 | 0.23 | 0.6 | 0.03 | 0.7 | 0.31 | |
9 | 4 | 4 | 3 | 8 | 1 | ||
Monoacylglycerol | 1-palmitoylglycerol (16:0) | 1.3 | 0.25 | 2.6 | 0.00 | 1.2 | 0.53 |
5 | 3 | 1 | 1 | 2 | 7 | ||
1-palmitoleoylglycerol (16:1)1 | 1.6 | 0.09 | 2.2 | 0.00 | 1.1 | 0.62 | |
2 | 3 | 7 | 8 | 3 | |||
1-oleoylglycerol (18:1) | 1.6 | 0.20 | 2.2 | 0.03 | 0.7 | 0.50 | |
5 | 5 | 6 | 4 | 7 | |||
1-linolenoylglycerol (18:3) | 1.5 | 0.07 | 2.0 | 0.00 | 1.0 | 0.82 | |
4 | 4 | 7 | 5 | 7 | 3 | ||
1-dihomo-linolenylglycerol (20:3) | 1.5 | 0.25 | 2.2 | 0.04 | 0.7 | 0.57 | |
5 | 1 | 6 | 7 | 4 | |||
1-arachidonylglycerol (20:4) | 1.5 | 0.21 | 2.3 | 0.01 | 1.1 | 0.78 | |
1 | 8 | 4 | 7 | 2 | 3 | ||
2-palmitoleoylglycerol (16:1)1 | 1.3 | 0.25 | 1.7 | 0.03 | 0.9 | 0.89 | |
4 | 7 | 7 | 4 | 6 | 8 | ||
2-arachidonoylglycerol (20:4) | 1.3 | 0.25 | 1.6 | 0.03 | 0.9 | 0.75 | |
1 | 3 | 8 | 5 | 1 | 2 | ||
Diacylglycerol | Linoleoyl-linolenoyl-glycerol (18:2/18:3) (2)1 | 1.3 | 0.51 | 1.6 | 0.29 | 3.3 | 0.03 |
4 | 7 | 1 | 6 | 2 | 9 | ||
Ceramides | N-palmitoyl-sphingosine (d18:1/16:0) | 0.9 | 0.73 | 0.6 | 0.00 | 0.7 | 0.04 |
6 | 1 | 9 | 8 | 3 | 9 | ||
N-stearoyl-sphingosine (d18:1/18:0)1 | 1.0 | 0.57 | 0.7 | 0.03 | 0.8 | 0.33 | |
9 | 8 | 1 | 3 | 9 | |||
N-palmitoyl-heptadecasphingosine (d17:1/16:0)1 | 0.9 | 0.95 | 0.7 | 0.04 | 0.8 | 0.20 | |
9 | 7 | 4 | 2 | 0 | |||
Hexosylceramides (HCER) | Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) | 0.7 | 0.04 | 0.6 | 0.00 | 0.6 | 0.02 |
4 | 8 | 2 | 3 | 7 | 9 | ||
Primary bile acid | Glycochenodeoxycholate | 0.9 | 0.75 | 1.8 | 0.00 | 0.8 | 0.54 |
8 | 6 | 3 | 7 | 0 | |||
Taurochenodeoxycholate | 1.0 | 0.98 | 1.6 | 0.45 | 0.8 | 1 | |
4 | 7 | 2 | 6 | 6 | |||
Secondary bile acid | Glycolithocholate sulfate | 0.9 | 0.70 | 1.4 | 0.01 | 1 | 1 |
5 | 3 | 2 | |||||
Deoxycholate | 0.9 | 0.79 | 0.6 | 0.12 | 0.7 | 0.00 | |
7 | 8 | 3 | 3 | 9 |
- Citation: Baxter BA, Parker KD, Nosler MJ, Rao S, Craig R, Seiler C, Ryan EP. Metabolite profile comparisons between ascending and descending colon tissue in healthy adults. World J Gastroenterol 2020; 26(3): 335-352
- URL: https://www.wjgnet.com/1007-9327/full/v26/i3/335.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i3.335